Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.37−0.34 (-3.90%)
Close on Nov 20, 2026Market cap $2.84BP/E –Yield –
Telix Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $426.44M, up 26.9% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $426.44M | +26.9% |
| FY2024 | Dec 31, 2024 | $336.16M | +60.4% |
| FY2023 | Dec 31, 2023 | $209.53M | – |
See a number that looks wrong?